Literature DB >> 15014578

Dosing of Selective Serotonin Reuptake Inhibitors.

Henry Chung1.   

Abstract

Year:  2001        PMID： 15014578      PMCID： PMC181220          DOI： 10.4088/pcc.v03n0507a

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  8 in total

1.  Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Authors:  M Fava; J F Rosenbaum; S L Hoog; R G Tepner; J B Kopp; M E Nilsson
Journal:  J Affect Disord       Date:  2000-08       Impact factor: 4.839

2.  The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial.

Authors:  E Schweizer; M Rynn; L A Mandos; N Demartinis; F García-España; K Rickels
Journal:  Int Clin Psychopharmacol       Date:  2001-05       Impact factor: 1.659

3.  Selecting a Selective Serotonin Reuptake Inhibitor: Clinically Important Distinguishing Features.

Authors:  Patricia A. Marken; J Stuart Munro
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-12

4.  Fluoxetine and sertraline dosages in major depression.

Authors:  R Cantrell; W Gillespie; L Altshuler
Journal:  Depress Anxiety       Date:  1999       Impact factor: 6.505

5.  The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies.

Authors:  J I Sheikh; P Londborg; C M Clary; R Fayyad
Journal:  Int Clin Psychopharmacol       Date:  2000-11       Impact factor: 1.659

6.  Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.

Authors:  J C Ballenger; D E Wheadon; M Steiner; W Bushnell; I P Gergel
Journal:  Am J Psychiatry       Date:  1998-01       Impact factor: 18.112

7.  Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.

Authors:  J Greist; G Chouinard; E DuBoff; A Halaris; S W Kim; L Koran; M Liebowitz; R B Lydiard; S Rasmussen; K White
Journal:  Arch Gen Psychiatry       Date:  1995-04

8.  Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.

Authors:  L F Fabre; F S Abuzzahab; M Amin; J L Claghorn; J Mendels; W M Petrie; S Dubé; J G Small
Journal:  Biol Psychiatry       Date:  1995-11-01       Impact factor: 13.382
  8 in total
  1 in total

1.  Genetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior.

Authors:  Karsten Kinast; Deborah Peeters; Sharon M Kolk; Dirk Schubert; Judith R Homberg
Journal:  Front Cell Neurosci       Date:  2013-06-12       Impact factor: 5.505
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.